Thyroid dermopathy and acropachy

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Graves' disease is an autoimmune condition commonly associated with thyroid dysfunction and with anti-thyroid antibodies, usually TSH receptor stimulating antibodies. Thyroid autoimmunity also may be associated with extra thyroidal manifestations. Most common extra thyroidal manifestation is ophthalmopathy. Less common is thyroid dermopathy, usually occurring in pretibial area. Dermopathy is almost always associated with ophthalmopathy and in severe cases with acropachy. A common antigen with thyroid in tissues of the skin and the eyes, most likely TSH receptor, is involved in pathogenesis of extra thyroidal manifestations. Presence of dermopathy and acropachy are predictors of severity of autoimmune process. Local corticosteroid application is the standard therapy for dermopathy. Response to therapy is good in mild cases and poor in severe cases. Immune modulators and biotherapies are undergoing randomized trials for ophthalmopathy component of Graves' disease. Any therapy proven to be effective for ophthalmopathy can be utilized in future for management of dermopathy.

Original languageEnglish (US)
Pages (from-to)553-565
Number of pages13
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Volume26
Issue number4
DOIs
StatePublished - Jan 1 2012

Fingerprint

Thyroid Gland
Graves Disease
Thyrotropin Receptors
Biological Therapy
Autoimmunity
Anti-Idiotypic Antibodies
Adrenal Cortex Hormones
Therapeutics
Antigens
Skin

Keywords

  • acropachy
  • dermopathy
  • Graves' disease
  • ophthalmopathy
  • pretibial myxedema
  • TSH receptor antibodies

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Thyroid dermopathy and acropachy. / Fatourechi, Vahab.

In: Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 26, No. 4, 01.01.2012, p. 553-565.

Research output: Contribution to journalReview article

@article{25b5ee5474344797bdfd75f6bc2b4c59,
title = "Thyroid dermopathy and acropachy",
abstract = "Graves' disease is an autoimmune condition commonly associated with thyroid dysfunction and with anti-thyroid antibodies, usually TSH receptor stimulating antibodies. Thyroid autoimmunity also may be associated with extra thyroidal manifestations. Most common extra thyroidal manifestation is ophthalmopathy. Less common is thyroid dermopathy, usually occurring in pretibial area. Dermopathy is almost always associated with ophthalmopathy and in severe cases with acropachy. A common antigen with thyroid in tissues of the skin and the eyes, most likely TSH receptor, is involved in pathogenesis of extra thyroidal manifestations. Presence of dermopathy and acropachy are predictors of severity of autoimmune process. Local corticosteroid application is the standard therapy for dermopathy. Response to therapy is good in mild cases and poor in severe cases. Immune modulators and biotherapies are undergoing randomized trials for ophthalmopathy component of Graves' disease. Any therapy proven to be effective for ophthalmopathy can be utilized in future for management of dermopathy.",
keywords = "acropachy, dermopathy, Graves' disease, ophthalmopathy, pretibial myxedema, TSH receptor antibodies",
author = "Vahab Fatourechi",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.beem.2011.10.001",
language = "English (US)",
volume = "26",
pages = "553--565",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Bailliere Tindall Ltd",
number = "4",

}

TY - JOUR

T1 - Thyroid dermopathy and acropachy

AU - Fatourechi, Vahab

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Graves' disease is an autoimmune condition commonly associated with thyroid dysfunction and with anti-thyroid antibodies, usually TSH receptor stimulating antibodies. Thyroid autoimmunity also may be associated with extra thyroidal manifestations. Most common extra thyroidal manifestation is ophthalmopathy. Less common is thyroid dermopathy, usually occurring in pretibial area. Dermopathy is almost always associated with ophthalmopathy and in severe cases with acropachy. A common antigen with thyroid in tissues of the skin and the eyes, most likely TSH receptor, is involved in pathogenesis of extra thyroidal manifestations. Presence of dermopathy and acropachy are predictors of severity of autoimmune process. Local corticosteroid application is the standard therapy for dermopathy. Response to therapy is good in mild cases and poor in severe cases. Immune modulators and biotherapies are undergoing randomized trials for ophthalmopathy component of Graves' disease. Any therapy proven to be effective for ophthalmopathy can be utilized in future for management of dermopathy.

AB - Graves' disease is an autoimmune condition commonly associated with thyroid dysfunction and with anti-thyroid antibodies, usually TSH receptor stimulating antibodies. Thyroid autoimmunity also may be associated with extra thyroidal manifestations. Most common extra thyroidal manifestation is ophthalmopathy. Less common is thyroid dermopathy, usually occurring in pretibial area. Dermopathy is almost always associated with ophthalmopathy and in severe cases with acropachy. A common antigen with thyroid in tissues of the skin and the eyes, most likely TSH receptor, is involved in pathogenesis of extra thyroidal manifestations. Presence of dermopathy and acropachy are predictors of severity of autoimmune process. Local corticosteroid application is the standard therapy for dermopathy. Response to therapy is good in mild cases and poor in severe cases. Immune modulators and biotherapies are undergoing randomized trials for ophthalmopathy component of Graves' disease. Any therapy proven to be effective for ophthalmopathy can be utilized in future for management of dermopathy.

KW - acropachy

KW - dermopathy

KW - Graves' disease

KW - ophthalmopathy

KW - pretibial myxedema

KW - TSH receptor antibodies

UR - http://www.scopus.com/inward/record.url?scp=84864743480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864743480&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2011.10.001

DO - 10.1016/j.beem.2011.10.001

M3 - Review article

C2 - 22863396

AN - SCOPUS:84864743480

VL - 26

SP - 553

EP - 565

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 4

ER -